Literature DB >> 18281467

Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay.

George Z Cheng1, Weizhou Zhang, Lu-Hai Wang.   

Abstract

Metastasis, the foremost cause of mortality in cancer patients, is increasingly recognized as a coordinated biological process. The multistep process of metastasis posts difficulty in studying its mechanism and molecular basis. Recent works have shown that the basic helix-loop-helix transcriptional factor Twist and the serine/threonine kinase AKT play pivotal roles in tumor development and progression. Our recent study has shown that AKT2 is a transcriptional regulatory target of Twist and acts downstream of Twist to promote cancer cell survival, migration, and invasion. Functional convergence of Twist and AKT2 underscores the importance of this signaling pathway in tumor development and progression and as a potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281467     DOI: 10.1158/0008-5472.CAN-07-5067

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  Basic helix-loop-helix transcription factor Twist1 inhibits transactivator function of master chondrogenic regulator Sox9.

Authors:  Shoujun Gu; Thomas G Boyer; Michael C Naski
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

2.  Oxidation of Akt2 kinase promotes cell migration and regulates G1-S transition in the cell cycle.

Authors:  Revati Wani; N Sharmila Bharathi; Jeffrey Field; Allen W Tsang; Cristina M Furdui
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

3.  Cytoskeletal rearrangement and Src and PI-3K-dependent Akt activation control GABA(B)R-mediated chemotaxis.

Authors:  Madhavi J Rane; Jon B Klein; Michelle T Barati; Janice Scherzer; Rui Wu
Journal:  Cell Signal       Date:  2015-02-26       Impact factor: 4.315

4.  miR-429 inhibits glioma invasion through BMK1 suppression.

Authors:  Weiyi Chen; Baogang Zhang; Wenjun Guo; Linlin Gao; Lihong Shi; Hongli Li; Shijun Lu; Yuqing Liu; Xiaolong Li
Journal:  J Neurooncol       Date:  2015-08-14       Impact factor: 4.130

5.  α-Parvin promotes breast cancer progression and metastasis through interaction with G3BP2 and regulation of TWIST1 signaling.

Authors:  Ying Sun; Yanyan Ding; Chen Guo; Chengmin Liu; Ping Ma; Shuang Ma; Zhe Wang; Jie Liu; Tao Qian; Luyao Ma; Yi Deng; Chuanyue Wu
Journal:  Oncogene       Date:  2019-02-25       Impact factor: 9.867

Review 6.  The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms.

Authors:  Yue Teng; Xu Li
Journal:  Clin Exp Metastasis       Date:  2013-10-26       Impact factor: 5.150

Review 7.  Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

Authors:  James A McCubrey; Stephen L Abrams; Kristin Stadelman; William H Chappell; Michelle Lahair; Richard A Ferland; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2009-11-04

Review 8.  Use of radionuclides in cancer research and treatment.

Authors:  M T Macías
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

9.  Alteration in TWIST expression: possible role in paclitaxel-induced apoptosis in human laryngeal carcinoma Hep-2 cell line.

Authors:  Liang Yu; Hui-Zheng Li; Su-Mei Lu; Wen-Wen Liu; Jian-Feng Li; Hai-Bo Wang; Wei Xu
Journal:  Croat Med J       Date:  2009-12       Impact factor: 1.351

Review 10.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.